Nevro is a medical device company that develops therapy and neuromodulation platform for the treatment of chronic pain.Read more
Medtronic is seen as one of Nevro's biggest rivals. Medtronic is headquartered in Minneapolis, Minnesota, and was founded in 1949. Like Nevro, Medtronic also works within the Health Care Equipment sector. Medtronic generates 8,292% the revenue of Nevro.
Boston Scientific is seen as one of Nevro's top competitors. Boston Scientific was founded in 1979, and its headquarters is in Marlborough, Massachusetts. Boston Scientific operates in the Health Care Equipment industry. Boston Scientific has 37,196 more employees than Nevro.
Nevro's revenue is the ranked 8th among it's top 10 competitors. The top 10 competitors average 5.8B. Over the last four quarters, Nevro's revenue has grown by 57.1%. Specifically, in Q1 2021's revenue was $88.6M; in Q4 2020, it was $109.7M; in Q3 2020, it was $108.5M; in Q2 2020, Nevro's revenue was $56.4M.
No recent acquisitions found related to Nevro
No recent investments found related to Nevro